200 related articles for article (PubMed ID: 30760060)
1. Aldose reductase inhibitors: 2013-present.
Quattrini L; La Motta C
Expert Opin Ther Pat; 2019 Mar; 29(3):199-213. PubMed ID: 30760060
[TBL] [Abstract][Full Text] [Related]
2. Novel aldose reductase inhibitors: a patent survey (2006--present).
Chatzopoulou M; Alexiou P; Kotsampasakou E; Demopoulos VJ
Expert Opin Ther Pat; 2012 Nov; 22(11):1303-23. PubMed ID: 22998509
[TBL] [Abstract][Full Text] [Related]
3. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
4. N-(Aroyl)-N-(arylmethyloxy)-α-alanines: Selective inhibitors of aldose reductase.
Nencetti S; La Motta C; Rossello A; Sartini S; Nuti E; Ciccone L; Orlandini E
Bioorg Med Chem; 2017 Jun; 25(12):3068-3076. PubMed ID: 28392277
[TBL] [Abstract][Full Text] [Related]
5. From a dull enzyme to something else: facts and perspectives regarding aldose reductase.
Del Corso A; Cappiello M; Mura U
Curr Med Chem; 2008; 15(15):1452-61. PubMed ID: 18537622
[TBL] [Abstract][Full Text] [Related]
6. Development of aldose reductase inhibitors for the treatment of inflammatory disorders.
Chatzopoulou M; Pegklidou K; Papastavrou N; Demopoulos VJ
Expert Opin Drug Discov; 2013 Nov; 8(11):1365-80. PubMed ID: 24090200
[TBL] [Abstract][Full Text] [Related]
7. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids.
Koukoulitsa C; Bailly F; Pegklidou K; Demopoulos VJ; Cotelle P
Eur J Med Chem; 2010 Apr; 45(4):1663-6. PubMed ID: 20071057
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
Rastelli G; Ferrari AM; Costantino L; Gamberini MC
Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.
Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C
Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
Bhadada SV; Vyas VK; Goyal RK
Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
[TBL] [Abstract][Full Text] [Related]
12. Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.
Giannoukakis N
Expert Opin Investig Drugs; 2008 Apr; 17(4):575-81. PubMed ID: 18363521
[TBL] [Abstract][Full Text] [Related]
13. Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylation.
Papastavrou N; Chatzopoulou M; Ballekova J; Cappiello M; Moschini R; Balestri F; Patsilinakos A; Ragno R; Stefek M; Nicolaou I
Eur J Med Chem; 2017 Apr; 130():328-335. PubMed ID: 28259841
[TBL] [Abstract][Full Text] [Related]
14. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase enzyme and its implication to major health problems of the 21(st) century.
Alexiou P; Pegklidou K; Chatzopoulou M; Nicolaou I; Demopoulos VJ
Curr Med Chem; 2009; 16(6):734-52. PubMed ID: 19199934
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase inhibitors for diabetic complications: Receptor induced atom-based 3D-QSAR analysis, synthesis and biological evaluation.
Vyas B; Singh M; Kaur M; Bahia MS; Jaggi AS; Silakari O; Singh B
J Mol Graph Model; 2015 Jun; 59():59-71. PubMed ID: 25911954
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and aldose reductase inhibitory activities of novel thienocinnolinone derivatives.
Pau A; Asproni B; Boatto G; Grella GE; De Caprariis P; Costantino L; Pinna GA
Eur J Pharm Sci; 2004 Mar; 21(4):545-52. PubMed ID: 14998586
[TBL] [Abstract][Full Text] [Related]
18. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
Suzen S; Buyukbingol E
Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
[TBL] [Abstract][Full Text] [Related]
19. The aldose reductase inhibitory capacity of Sorbus domestica fruit extracts depends on their phenolic content and may be useful for the control of diabetic complications.
Termentzi A; Alexiou P; Demopoulos VJ; Kokkalou E
Pharmazie; 2008 Sep; 63(9):693-6. PubMed ID: 18819524
[TBL] [Abstract][Full Text] [Related]
20. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
